Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: Does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?

Fertility and Sterility

Volumn 96, Issue 4, 2011, Pages 872-876

  Guivarc'H Levêque, Anne ^a   Homer, Lionel ^a   Arvis, Philippe ^a   Broux, Pierre Louis ^a   Moy, Ludovic ^a   Priou, Gérard ^a   Vialard, Jean ^a   Colleu, Daniel ^b   Dewailly, Didier ^c  

^a Clinique Mutualiste La Sagesse   (France)

^b Laboratoire de biologie réunie   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

controlled ovarian hyperstimulation; estradiol pretreatment; GnRH antagonist; IVF; LH; pregnancy rate; programming

Indexed keywords

CHORIONIC GONADOTROPIN; DYDROGESTERONE; ESTRADIOL; GESTAGEN; GONADORELIN; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; PROVAMES; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH RATE; DRUG EXPOSURE; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUATION; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; ESTRADIOL; ESTROGENS; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTE RETRIEVAL; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84860423479     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.07.1138     Document Type: Article

References (14)

1. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum Reprod Update 12 2006 651 671 (Pubitemid 44605507)
2. B.C. Fauser, and P. Devroey Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 83 2005 1607 1611 (Pubitemid 40834230)
3. C. de Klerk, N.S. Macklon, E.M. Heijnen, M.J. Eijkemans, B.C. Fauser, and J. Passchier The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy Hum Reprod 22 2007 2554 2558 (Pubitemid 47289072)
4. A.D. Domar, K. Smith, L. Conboy, M. Iannone, and M. Alper A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment Fertil Steril 94 2010 1457 1459
5. A.K. Schroder, A. Katalinic, K. Diedrich, and M. Ludwig Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients Reprod Biomed Online 8 2004 600 606 (Pubitemid 38660494)
6. M.F. Verberg, M.J. Eijkemans, E.M. Heijnen, F.J. Broekmans, C. de Klerk, and B.C. Fauser Why do couples drop-out from IVF treatment? A prospective cohort study Hum Reprod 23 2008 2050 2055
7. G. Griesinger, E.M. Kolibianakis, C. Venetis, K. Diedrich, and B. Tarlatzis Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis Fertil Steril 94 2010 2382 2384
8. B. Smulders, S.M. van Oirschot, C. Farquhar, L. Rombauts, and J.A. Kremer Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques Cochrane Database Syst Rev 2010 CD006109
9. E. le Nestour, J. Marraoui, N. Lahlou, M. Roger, D. de Ziegler, and P. Bouchard Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition J Clin Endocrinol Metab 77 1993 439 442 (Pubitemid 23230054)
10. I. Cedrin-Durnerin, B. Bstandig, I. Parneix, V. Bied-Damon, C. Avril, and C. Decanter Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol Hum Reprod 22 2007 109 116 (Pubitemid 44942673)
11. A. Guivarc'h-Leveque, P. Arvis, J.L. Bouchet, P.L. Broux, L. Moy, and G. Priou Efficacité de la programmation des cycles FIV en antagonistes par les estrognes Gynecol Obstet Fertil 38 2010 1822
12. I. Cédrin-Durnerin, A. Guivarc'h-Levêque, B. Bstandig, I. Parneix, F. Lesourd, and M. Le Marthelot Influence of steroids pretreatments on ovarian stimulation parameters in patients enrolled in IVF/ICSI cycles with antagonists Hum Reprod 24 Suppl 1 2009 i113
13. B. Couzinet, and G. Schaison The control of gonadotrophin secretion by ovarian steroids Hum Reprod 8 Suppl 2 1993 97 101 (Pubitemid 23337185)
14. J.A. Huirne, R. Homburg, and C.B. Lambalk Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 22 2007 2805 2813 (Pubitemid 351696806)